(Press-News.org) Green hydrogen can be produced through water electrolysis technology, which uses renewable energy to split water into hydrogen and oxygen without emitting carbon dioxide. However, the production cost of green hydrogen is currently around $5 per kilogram, which is two to three times higher than gray hydrogen obtained from natural gas. For the practical use of green hydroten, the innovation in water electrolysis technology is required for the realization of hydrogen economy, especially for Korea where the utilization of renewable energy is limited owing to geographical reasons.
Dr. Kyung Joong Yoon’s research team at the Energy Materials Research Center of the Korea Institute of Science and Technology (KIST) has developed a nanocatalyst for high-temperature water electrolysis that can retain a high current density of more than 1A/cm2 for a long time at temperatures above 600 degrees. While the degradation mechanisms of nanomaterials at high temperatures have been elusive thus far, the team identified the fundamental reasons of abnormal behavior of nanomateirals and successfully resolved issues, eventually improving performance and stability in realistic water electrolysis cells.
The electrolysis technology can be classified into low- and high-temperature electrolysis. While low-temperature electrolysis operating at temperatures below 100 degrees Celsius has long been developed and is technologically more mature, high-temperature electrolysis operating above 600 degrees Celsius offers higher efficiency and is considered as a next-generation technology with a strong potential for further cost-down. However, its commercialization has been hindered by the lack of thermal stability and insufficient lifetime owing to high-temperature degradation, such as corrosion and structural deformation. In particular, nanocatalysts, which are widely used to improve the performance of low-temperature water electrolyzers, quickly deteriorate at high operating temperatures, making it difficult to effectively use them for high-temperature water electrolysis.
To overcome this limitation, the team developed a new nanocatalyst synthetic techniques that suppresses the formation of harmful compounds causing high temperature degradation. By systematically analyzing the nanoscale phenomena using transmission electron microscopy, the researchers identified specific substances causing severe structural alterations, such as strontium carbonate and cobalt oxide and successfully removed them to achieve highly stable nanocatalysts in terms of chemical and physical properties.
When the team applied the nanocatalyst to a high-temperature water electrolysis cell, it more than doubled hydrogen production rate and operated for more than 400 hours at 650 degrees without degradation. This technique was also sucessfully applied to a practical large-area water electrolysis cell, confirming its strong potential for scale-up and commercial use.
"Our newly developed nanomaterials achieved both high performance ans stability for high-temperature water electrolysis technology, and it can contribute to lower the production cost of green hydrogen, making it economically competitive with gray hydrogen in the future," said Dr. Kyungjoong Yoon of KIST. "For commercialization, we plan to develop automated processing techniques for mass production in cooperation with industry cell manufacturers."
###
KIST was established in 1966 as the first government-funded research institute in Korea. KIST now strives to solve national and social challenges and secure growth engines through leading and innovative research. For more information, please visit KIST’s website at https://eng.kist.re.kr/
This research was supported by the Ministry of Science and ICT (Minister Lee Jong-ho) through the KIST Major Project and Climate Change Response Technology Development Project (2020M1A2A2080862), and the results were published in the latest issue of the Chemical Engineering Journal (IF 15.1, top 3.2% in JCR), an international journal in the field of chemical engineering.
END
Developing nanocatalysts to overcome limitations of water electrolysis technology
Developing nanocatalysts that do not degrade at high temperatures above 600 degrees Celsius, more than doubling green hydrogen production with high-temperature water electrolysis cells
2023-12-28
ELSE PRESS RELEASES FROM THIS DATE:
Blood poisoning keeping many people out of work
2023-12-28
A few years ago, the World Health Organization estimated that blood poisoning, or sepsis, is involved in one in five deaths in the world. 11 million people die from sepsis each year, of which nearly 3 million are children.
This is also a problem in Norway, with thousands of people affected every year.
“Sepsis is a severe immunological overreaction to an infection. It causes the body’s organs to fail,” says Nina Vibeche Skei. She is a doctoral research fellow at the Norwegian University of Science and Technology (NTNU) and a senior anaesthetist ...
Oral peptides: A new era in drug development
2023-12-28
For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat surfaces or require specificity for particular protein homologs. Typically, larger biologics that can target these proteins demand injection, limiting patient convenience and accessibility.
In a new study published in Nature Chemical Biology, scientists from the laboratory of Professor Christian Heinis at EPFL have achieved a significant milestone in drug development. Their research ...
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
2023-12-28
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.
AFCR’s BRACE (Bridging Research from Academia to Cancer Entrepreneurship) Award Venture Competition is designed to support and accelerate oncology innovations on their path toward commercialization, with the ultimate goal of improving outcomes for patients affected by cancer globally. AFCR aims to support the winners of the BRACE Award with funding resources, advisory experts, and access to our global network of key opinion leaders in cancer research.
The winner of the BRACE ...
Social media platforms generate billions in annual ad revenue from US youth
2023-12-27
Embargoed for release: December 27, 2023, 2:00 PM ET
Key points:
Researchers estimated that Facebook, Instagram, Snapchat, TikTok, X (formerly Twitter), and YouTube collectively derived nearly $11 billion in advertising revenue during 2022 from U.S. youth, who are vulnerable to negative mental health outcomes.
The study is the first to offer estimates of the number of youth users on these platforms and how much annual ad revenue is attributable to them.
According to the researchers, the study’s ...
Virtual care works best when patients see their own family doctor, study finds
2023-12-27
Toronto, ON, December 27, 2023 – Compared to patients who had a virtual visit with their own family doctor, those who received virtual care from a doctor outside of their family care team were 66 percent more likely to visit the emergency department within seven days, according to new research.
The study, led by researchers at the University Health Network (UHN), Unity Health Toronto, and ICES, also showed that patients receiving virtual care outside of an existing family doctor-patient relationship were 25 percent more likely to have an in-person visit and 88 percent more likely to have another virtual visit within seven days.
“This study sheds light on how different types ...
Consistency and accuracy of AI for providing nutritional information
2023-12-27
About The Study: The results of this study suggest that artificial intelligence (AI) can be a useful and convenient tool for people who want to know the energy and macronutrient information of their foods. Although AI chatbots cannot replace nutritionists, they may provide real-time analysis of foods, and the capacity to harness AI technology in a supportive role may fundamentally transform the way nutritionists communicate with patients.
Authors: Jung-Su Chang, Ph.D., of Taipei Medical University in Taipei, Taiwan, is the corresponding author.
To ...
Low-carbohydrate diet macronutrient quality and weight change
2023-12-27
About The Study: In this study using data from three large prospective cohort studies among 123,000 individuals, low-carbohydrate diets that emphasized high-quality proteins, fats and carbohydrates from whole grains and other healthy plant-based foods were significantly associated with slower weight gain in the long term. In contrast, low-carbohydrate diets emphasizing animal-sourced proteins and fats or refined carbohydrates were associated with faster weight gain.
Authors: Qi Sun, M.D., Sc.D., of the Harvard T.H. Chan School of Public Health in Boston, is the corresponding author.
To access the ...
Benzodiazepine use during pregnancy and risk of miscarriage
2023-12-27
About The Study: This nationwide case-time-control study revealed an increased risk of miscarriage associated with benzodiazepine use during pregnancy after accounting for measurable confounders, and results were unlikely to be due to unmeasured confounding. These findings underscore the necessity for health care professionals to meticulously balance the risk-benefit ratio when considering the use of benzodiazepines to treat psychiatric and sleep disorders during pregnancy.
Authors: Fei-Yuan Hsiao, Ph.D., of National ...
Comparison of capture rates of the National Cancer Database across race and ethnicity
2023-12-27
About The Study: In this study of individuals diagnosed with cancer in the National Cancer Database (NCDB), Hispanic and American Indian or Alaska Native individuals diagnosed with breast, colorectal, lung, and prostate cancer were undercaptured in the NCDB, but their representation improved over time. Increased study is needed to determine where these populations predominantly seek cancer care.
Authors: Juan Javier-DesLoges, M.D., M.S., of the University of California, San Diego, is the corresponding author.
To ...
A study of the genetics of pericarditis increases understanding of newly approved drug treatment
2023-12-27
A study of the genetics of pericarditis increases understanding of newly approved drug treatment
Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these cytokines and new a study from deCODE genetics and collaborators can contribute to the further development of this treatment.
A new study called “Variants at the interleukin-1 gene locus and pericarditis” was published today in the journal JAMA Cardiology, by scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Denmark, USA, and Iceland.
The study involves ...
LAST 30 PRESS RELEASES:
How rice plants tell head from toe during early growth
Scientists design solar-responsive biochar that accelerates environmental cleanup
Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy
DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer
Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
Neg-entropy is the true drug target for chronic diseases
Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis
Early TB treatment reduced deaths from sepsis among people with HIV
Palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke
Structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity
Therapeutic drug monitoring of biologics in inflammatory bowel disease: An evidence-based multidisciplinary guidelines
New global review reveals integrating finance, technology, and governance is key to equitable climate action
New study reveals cyanobacteria may help spread antibiotic resistance in estuarine ecosystems
Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report
How cultural norms shape childhood development
University of Phoenix research finds AI-integrated coursework strengthens student learning and career skills
Next generation genetics technology developed to counter the rise of antibiotic resistance
Ochsner Health hospitals named Best-in-State 2026
A new window into hemodialysis: How optical sensors could make treatment safer
High-dose therapy had lasting benefits for infants with stroke before or soon after birth
‘Energy efficiency’ key to mountain birds adapting to changing environmental conditions
Scientists now know why ovarian cancer spreads so rapidly in the abdomen
USF Health launches nation’s first fully integrated institute for voice, hearing and swallowing care and research
Why rethinking wellness could help students and teachers thrive
Seabirds ingest large quantities of pollutants, some of which have been banned for decades
When Earth’s magnetic field took its time flipping
Americans prefer to screen for cervical cancer in-clinic vs. at home
Rice lab to help develop bioprinted kidneys as part of ARPA-H PRINT program award
Researchers discover ABCA1 protein’s role in releasing molecular brakes on solid tumor immunotherapy
[Press-News.org] Developing nanocatalysts to overcome limitations of water electrolysis technologyDeveloping nanocatalysts that do not degrade at high temperatures above 600 degrees Celsius, more than doubling green hydrogen production with high-temperature water electrolysis cells




